Blockade of Nuclear Factor-kappaB Signaling Pathway and Anti-inflammatory Activity of Cardamomin, a Chalcone Analog from Alpinia Conchigera
Overview
Authors
Affiliations
Nuclear factor-kappaB (NF-kappaB) and the signaling pathways that regulate its activity have become a focal point for intense drug discovery and development efforts. NF-kappaB regulates the transcription of a large number of genes, particularly those involved in immune, inflammatory, and antiapoptotic responses. In our search for NF-kappaB inhibitors from natural resources, we identified cardamomin, 2',4'-dihydroxy-6'-methoxychalcone, as an inhibitor of NF-kappaB activation from Alpinia conchigera Griff (Zingiberaceae). In present study, we demonstrated the effect of cardamomin on NF-kappaB activation in lipopolysaccharide (LPS)-stimulated RAW264.7 cells and LPS-induced mortality. This compound significantly inhibited the induced expression of NF-kappaB reporter gene by LPS or tumor necrosis factor (TNF)-alpha in a dose-dependent manner. LPS-induced production of TNF-alpha and NO as well as expression of inducible nitric-oxide synthase and cyclooxygenase-2 was significantly suppressed by the treatment of cardamomin in RAW264.7 cells. Also, cardamomin inhibited not only LPS-induced degradation and phosphorylation of inhibitor kappaBalpha (IkappaBalpha) but also activation of inhibitor kappaB (IkappaB) kinases and nuclear translocation of NF-kappaB. Further analyses revealed that cardamomin did not directly inhibit IkappaB kinases, but it significantly suppressed LPS-induced activation of Akt. Moreover, cardamomin suppressed transcriptional activity and phosphorylation of Ser536 of RelA/p65 subunit of NF-kappaB. However, this compound did not inhibit LPS-induced activation of extracellular signal-regulated kinase and stress-activated protein kinase/c-Jun NH(2)-terminal kinase, but significantly impaired activation of p38 mitogen-activated protein kinase. We also demonstrated that pretreatment of cardamomin rescued C57BL/6 mice from LPS-induced mortality in conjunction with decreased serum level of TNF-alpha. Together, cardamomin could be valuable candidate for the intervention of NF-kappaB-dependent pathological condition such as inflammation.
Li W, Cheng X, Zhu G, Hu Y, Wang Y, Niu Y Front Pharmacol. 2024; 15:1340855.
PMID: 38572424 PMC: 10987752. DOI: 10.3389/fphar.2024.1340855.
Pratelli G, Tamburini B, Carlisi D, De Blasio A, DAnneo A, Emanuele S Int J Mol Sci. 2023; 24(19).
PMID: 37834065 PMC: 10572570. DOI: 10.3390/ijms241914619.
Yuandani , Jantan I, Haque M, Rohani A, Nugraha S, Salim E Front Pharmacol. 2023; 14:1222195.
PMID: 37533631 PMC: 10391552. DOI: 10.3389/fphar.2023.1222195.
Jamieson P, Carbonero F, Stevens J Curr Res Food Sci. 2023; 6:100521.
PMID: 37266414 PMC: 10230173. DOI: 10.1016/j.crfs.2023.100521.
Barber K, Mendonca P, Soliman K Brain Sci. 2023; 13(1).
PMID: 36672126 PMC: 9856590. DOI: 10.3390/brainsci13010145.